Edition:
United States

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,703.50GBp
14 Jun 2019
Change (% chg)

-- (--)
Prev Close
1,703.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,185,872
52-wk High
1,713.50
52-wk Low
1,242.50

Select another date:

Fri, May 17 2019

BRIEF-Dantax Receives Tender Offer For Its Shares In Opus Acoustics And Ansuz-Acoustics

* SAID ON THURSDAY RECEIVED TENDER OFFER FOR ALL ITS SHARES IN ASSOCIATED COMPANIES, OPUS ACOUSTICS AND ANSUZ-ACOUSTICS

Nivea-maker Beiersdorf buys Coppertone for $550 million

BERLIN Beiersdorf, the maker of Nivea and other skin care brands, is buying U.S. sun care brand Coppertone from Bayer for $550 million to strengthen its position in North America, the German consumer goods firm said on Monday.

UPDATE 2-Smith & Nephew lifts revenue view after best quarter since 2015

* Shares rise 3.5 percent (Rewrites, adds CEO comment; updates shares)

Smith & Nephew boosts full-year outlook after Q1 growth

May 2 Medical products maker Smith & Nephew on Thursday forecast annual revenue growth at the top half of its previously estimated range after reporting a 4.4 percent rise in quarterly revenue on an underlying basis.

Nivea revamp boosts Beiersdorf's sales

BERLIN German consumer goods firm Beiersdorf reported a recovery in sales of its Nivea skin cream and its premium La Prairie brand in the first quarter after a new chief executive pledged more investment to fight niche brands.

Nivea-maker Beiersdorf reports strong first quarter

BERLIN, April 30 German consumer goods firm Beiersdorf reported a strong start to the year on Tuesday on healthy sales of its Nivea skin cream after its new chief executive launched a new strategy to help the firm compete with niche brands.

Deals of the day-Mergers and acquisitions

March 12 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Britain's Smith & Nephew to buy Osiris in regenerative products push

Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

UPDATE 1-Britain's Smith & Nephew to buy Osiris in regenerative products push

March 12 Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

Smith & Nephew to buy Osiris Therapeutics for $660 mln

March 12 British medical products maker Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as it looks to boost profit margins and find new sources of growth.

Select another date: